Encapsulation of Nutraceutical Ingredients in Liposomes and Their Potential for Cancer Treatment

References

• Badawi AM: Important Facts about Cancer Prevention. Victoria, Canada: Trafford Publishing, 2012.
   Google Scholar
• Kandile NG: Nanotechnology and cancer prevention, detection and treatment, In: Important Facts about Cancer Prevention. Victoria, Canada: Trafford Publishing, 2012.
   Google Scholar
• Shukla Y and George J: Combinatorial strategies employing nutraceuticals for cancer development. Ann N Y Acad Sci 1229, 162–175, 2011.
   PubMed Web of Science ®Google Scholar
• Santos IS, Ponte BM, Boonme P, Silva AM, and Souto EB: Nanoencapsulation of polyphenols for protective effect against colon–rectal cancer. Biotechnol Adv 31, 514–523, 2013.
   PubMed Web of Science ®Google Scholar
• Mehta RG, Murillo G, Naithani R, and Peng X: Cancer chemoprevention by natural products: How far have we come? Pharm Res 27, 950–961, 2010.
   PubMed Web of Science ®Google Scholar
• Arora D and Jaglan S: Nanocarriers based delivery of nutraceuticals for cancer prevention and treatment: a review of recent research developments. Trends Food Sci Technol 54, 114–126, 2016.
   Web of Science ®Google Scholar
• Mozafari M and Mortazavi S: Nanoliposomes: From Fundamentals to Recent Developments. Victoria, Canada: Trafford Publishing, 2005.
   Google Scholar
• Riaz M: Liposomes preparation methods. Pak J Pharm Sci 9, 65–77, 1996.
   PubMedGoogle Scholar
• Aadinath W, Bhushani A, and Anandharamakrishnan C: Synergistic radical scavenging potency of curcumin-in-β-cyclodextrin-in-nanomagnetoliposomes. Mater Sci Eng C Mater Biol Appl 64, 293–302, 2016.
   PubMed Web of Science ®Google Scholar
• Thangapazham RL, Puri A, Tele S, Blumenthal R, and Maheshwari RK: Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells. Int J Oncol 32, 1119–1123, 2008.
   PubMed Web of Science ®Google Scholar
• Catania A, Barrajón-Catalán E, Nicolosi S, Cicirata F, and Micol V: Immunoliposome encapsulation increases cytotoxic activity and selectivity of curcumin and resveratrol against HER2 overexpressing human breast cancer cells. Breast Cancer Res Treat 141, 55–65, 2013.
   PubMed Web of Science ®Google Scholar
• Kunwar A, Barik A, Pandey R, and Priyadarsini KI: Transport of liposomal and albumin loaded curcumin to living cells: an absorption and fluorescence spectroscopic study. Biochim Biophys Acta (BBA)-General Subjects 1760, 1513–1520, 2006.
   PubMed Web of Science ®Google Scholar
• Allen TM: Liposomes: opportunities in drug delivery. Drugs 54, 8–14, 1997.
   PubMed Web of Science ®Google Scholar
• Lee KD, Nir S, and Papahadjopoulos D: Quantitative analysis of liposome-cell interactions in vitro: rate constants of binding and endocytosis with suspension and adherent J774 cells and human monocytes. Biochemistry 32, 889–899, 1993.
   PubMed Web of Science ®Google Scholar
• Pandelidou M, Dimas K, Georgopoulos A, Hatziantoniou S, and Demetzos C: Preparation and characterization of lyophilised EGG PC liposomes incorporating curcumin and evaluation of its activity against colorectal cancer cell lines. J Nanosci Nanotechnol 11, 1259–1266, 2011.
   PubMed Web of Science ®Google Scholar
• Jobin C, Bradham CA, Russo MP, Juma B, Narula AS, et al.: Curcumin blocks cytokine-mediated NF-κB activation and proinflammatory gene expression by inhibiting inhibitory factor I-κB kinase activity. J Immunol 163, 3474–3483, 1999.
   PubMed Web of Science ®Google Scholar
• Zlotogorski A, Dayan A, Dayan D, Chaushu G, Salo T, et al.: Nutraceuticals as new treatment approaches for oral cancer-I: Curcumin. Oral Oncol 49, 187–191, 2013.
   PubMed Web of Science ®Google Scholar
• Li L, Braiteh FS, and Kurzrock R: Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 104, 1322–1331, 2005.
   PubMed Web of Science ®Google Scholar
• Khopde SM, Indira Priyadarsini K, Palit DK, and Mukherjee T: Effect of solvent on the excited-state photophysical properties of curcumin. Photochem Photobiol 72, 625–631, 2000.
   PubMed Web of Science ®Google Scholar
• Wang D, Veena MS, Stevenson K, Tang C, Ho B, et al.: Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway. Clin Cancer Res 14, 6228–6236, 2008.
   PubMed Web of Science ®Google Scholar
• Saengkrit N, Saesoo S, Srinuanchai W, Phunpee S, and Ruktanonchai UR: Influence of curcumin-loaded cationic liposome on anticancer activity for cervical cancer therapy. Colloids Surf B Biointerfaces 114, 349–356, 2014.
   PubMed Web of Science ®Google Scholar
• Lu X-Y, Hu S, Jin Y, and Qiu L-Y: Application of liposome encapsulation technique to improve anti-carcinoma effect of resveratrol. Drug Dev Ind Pharm 38, 314–322, 2012.
   PubMed Web of Science ®Google Scholar
• Neves AR, Martins S, Segundo MA, and Reis S: Nanoscale delivery of resveratrol towards enhancement of supplements and nutraceuticals. Nutrients 8, 131, 2016.
   PubMed Web of Science ®Google Scholar
• Wang X, Li Y, Yao H, Ju R, Zhang Y, et al.: The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol-distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in resistant lung cancer cells. Biomaterials 32, 5673–5687, 2011.
   PubMed Web of Science ®Google Scholar
• Narayanan NK, Nargi D, Randolph C, and Narayanan BA: Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. Int J Cancer 125, 1–8, 2009.
   PubMed Web of Science ®Google Scholar
• Mendes D, Alves C, Afonso N, Cardoso F, Passos-Coelho JL, et al.: The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer – a systematic review. Breast Cancer Res 17, 140, 2015.
   PubMed Web of Science ®Google Scholar
• Mignet N, Seguin J, Romano MR, Brullé L, Touil YS, et al.: Development of a liposomal formulation of the natural flavonoid fisetin. Int J Pharm 423, 69–76, 2012.
   PubMed Web of Science ®Google Scholar
• Seguin J, Brullé L, Boyer R, Lu YM, Romano MR, et al.: Liposomal encapsulation of the natural flavonoid fisetin improves bioavailability and antitumor efficacy. Int J Pharm 444, 146–154, 2013.
   PubMed Web of Science ®Google Scholar
• Mousavi SH, Moallem SA, Mehri S, Shahsavand S, Nassirli H, et al.: Improvement of cytotoxic and apoptogenic properties of crocin in cancer cell lines by its nanoliposomal form. Pharm Biol 49, 1039–1045, 2011.
   PubMed Web of Science ®Google Scholar
• Aung H, Wang C, Ni M, Fishbein A, Mehendale S, et al.: Crocin from Crocus sativus possesses significant anti-proliferation effects on human colorectal cancer cells. Exp Oncol 29, 175–180, 2007.
   PubMedGoogle Scholar
• Liang T, Guan R, Wang Z, Shen H, Xia Q, et al.: Comparison of anticancer activity and antioxidant activity between cyanidin-3-O-glucoside liposomes and cyanidin-3-O-glucoside in Caco-2 cells in vitro. RSC Adv 7, 37359–37368, 2017.
   Web of Science ®Google Scholar
• Phan V, Walters J, Brownlow B, and Elbayoumi T: Enhanced cytotoxicity of optimized liposomal genistein via specific induction of apoptosis in breast, ovarian and prostate carcinomas. J Drug Target 21, 1001–1011, 2013.
   PubMed Web of Science ®Google Scholar
• Halwani M, Hossain Z, Khiyami MA, and Omri A: Liposomal β-glucan: preparation, characterization and anticancer activities. J Nanomed-Nanotechnol 6, 7, 2015.
   Google Scholar
• de Pace RCC, Liu X, Sun M, Nie S, Zhang J, et al.: Anticancer activities of (−)-epigallocatechin-3-gallate encapsulated nanoliposomes in MCF7 breast cancer cells. J Liposome Res 23, 187–196, 2013.
   PubMed Web of Science ®Google Scholar
• Fang J-Y, Lee W-R, Shen S-C, and Huang Y-L: Effect of liposome encapsulation of tea catechins on their accumulation in basal cell carcinomas. J Dermatol Sci 42, 101–109, 2006.
   PubMed Web of Science ®Google Scholar
• Gharib A, Faezizadeh Z, and Godarzee M: Preparation and characterization of nanoliposomal beta-cryptoxanthin and its effect on proliferation and apoptosis in human leukemia cell line K562. Trop J Pharm Res 14, 187–194, 2015.
   Web of Science ®Google Scholar
• Ma X, Zhou J, Zhang C-X, Li X-Y, Li N, et al.: Modulation of drug-resistant membrane and apoptosis proteins of breast cancer stem cells by targeting berberine liposomes. Biomaterials 34, 4452–4465, 2013.
   PubMed Web of Science ®Google Scholar
• Yi C, Fu M, Cao X, Tong S, Zheng Q, et al.: Enhanced oral bioavailability and tissue distribution of a new potential anticancer agent, Flammulina velutipes sterols, through liposomal encapsulation. J Agric Food Chem 61, 5961–5971, 2013.
   PubMed Web of Science ®Google Scholar
• Rodrigues ARO, Mendes PMF, Silva PML, Machado VA, Almeida BG, et al.: Solid and aqueous magnetoliposomes as nanocarriers for a new potential drug active against breast cancer. Colloids Surf B Biointerfaces 158, 460–468, 2017. doi:10.1016/j.colsurfb.2017.07.015.
   PubMed Web of Science ®Google Scholar
• Clares B, Biedma-Ortiz RA, Sáez-Fernández E, Prados JC, Melguizo C, et al.: Nano-engineering of 5-fluorouracil-loaded magnetoliposomes for combined hyperthermia and chemotherapy against colon cancer. Eur J Pharm Biopharm 85, 329–338, 2013.
   PubMed Web of Science ®Google Scholar
• Das AK, Marwal A, and Verma R: Preparation and characterization of nano-bio hybrid based magneto liposome. Int J Pharm Sci Res 6, 367, 2015.
   Web of Science ®Google Scholar
• Cardoso BD, Rio IS, Rodrigues ARO, Almeida B, Araújo JP, et al.: Magnetoliposomes Containing Magnesium Ferrite Nanoparticles for Enhanced Therapeutic Potential of Curcumin. Abstract published at NaNaX 8-Nanoscience with Nanocrystals held at Braga, July 3–7, 2017.
   Google Scholar
• Li X, Ruan G-R, Lu W-L, Hong H-Y, Liang G-W, et al.: A novel stealth liposomal topotecan with amlodipine: apoptotic effect is associated with deletion of intracellular Ca2+ by amlodipine thus leading to an enhanced antitumor activity in leukemia. J Control Release 112, 186–198, 2006.
   PubMed Web of Science ®Google Scholar
• Mu L, Ju R, Liu R, Bu Y-Z, Zhang J, et al.: Dual-functional drug liposomes in treatment of resistant cancers. Adv Drug Deliv Rev 115, 46–56, 2017.
   PubMed Web of Science ®Google Scholar
• Li Y, Revalde JL, Reid G, and Paxton JW: Interactions of dietary phytochemicals with ABC transporters: possible implications for drug disposition and multidrug resistance in cancer. Drug Metab Rev 42, 590–611, 2010.
   PubMed Web of Science ®Google Scholar
• Taur JS and Rodriguez-Proteau R: Effects of dietary flavonoids on the transport of cimetidine via P-glycoprotein and cationic transporters in Caco-2 and LLC-PK1 cell models. Xenobiotica 38, 1536–1550, 2008.
   PubMed Web of Science ®Google Scholar
• Satsu H, Hiura Y, Mochizuki K, Hamada M, and Shimizu M: Activation of pregnane X receptor and induction of MDR1 by dietary phytochemicals. J Agric Food Chem 56, 5366–5373, 2008.
   PubMed Web of Science ®Google Scholar
• Wu C-P, Klokouzas A, Hladky SB, Ambudkar SV, and Barrand MA: Interactions of mefloquine with ABC proteins, MRP1 (ABCC1) and MRP4 (ABCC4) that are present in human red cell membranes. Biochem Pharmacol 70, 500–510, 2005.
   PubMed Web of Science ®Google Scholar
• Misra R and Sahoo SK: Coformulation of doxorubicin and curcumin in poly(D,L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells. Mol Pharm 8, 852–866, 2011.
   PubMed Web of Science ®Google Scholar
• Friberg S and Nyström AM: NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer? J Nanobiotechnology 14, 17, 2016.
   PubMed Web of Science ®Google Scholar
• Sarkar FH and Li Y: Harnessing the fruits of nature for the development of multi-targeted cancer therapeutics. Cancer Treat Rev 35, 597–607, 2009.
   PubMed Web of Science ®Google Scholar
• Li Y and Sarkar FH: Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein. Cancer Lett 186, 157–164, 2002.
   PubMed Web of Science ®Google Scholar
• Meng J, Guo F, Xu H, Liang W, Wang C, et al.: Combination therapy using co-encapsulated resveratrol and paclitaxel in liposomes for drug resistance reversal in breast cancer cells in vivo. Sci Rep 6, 22390, 2016.
   PubMed Web of Science ®Google Scholar
• Imai Y, Tsukahara S, Asada S, and Sugimoto Y: Phytoestrogens/flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance. Cancer Res 64, 4346–4352, 2004.
   PubMed Web of Science ®Google Scholar
• Nabekura T, Yamaki T, Ueno K, and Kitagawa S: Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals. Cancer Chemother Pharmacol 62, 867–873, 2008.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wei D, and Liu J: In vivo reversal of doxorubicin resistance by (−)-epigallocatechin gallate in a solid human carcinoma xenograft. Cancer Lett 208, 179–186, 2004.
   PubMed Web of Science ®Google Scholar
• Shinkai M, Yanase M, Honda H, Wakabayashi T, Yoshida J, et al.: Intracellular hyperthermia for cancer using magnetite cationic liposomes: in vitro study. Jpn J Cancer Res 87, 1179–1183, 1996.
   PubMedGoogle Scholar
• Le B, Shinkai M, Kitade T, Honda H, Yoshida J, et al.: Preparation of tumor-specific magnetoliposomes and their application for hyperthermia. J Chem Eng Japan / JCEJ 34, 66–72, 2001.
   Web of Science ®Google Scholar
• Shinkai M, Le B, Honda H, Yoshikawa K, Shimizu K, et al.: Targeting hyperthermia for renal cell carcinoma using human MN antigen-specific magnetoliposomes. Jpn J Cancer Res 92, 1138–1146, 2001.
   PubMedGoogle Scholar
• Hamaguchi S, Tohnai I, Ito A, Mitsudo K, Shigetomi T, et al.: Selective hyperthermia using magnetoliposomes to target cervical lymph node metastasis in a rabbit tongue tumor model. Cancer Sci 94, 834–839, 2003.
   PubMed Web of Science ®Google Scholar
• Kullberg M, Mann K, and Owens JL: Improved drug delivery to cancer cells: a method using magnetoliposomes that target epidermal growth factor receptors. Med Hypotheses 64, 468–470, 2005.
   PubMed Web of Science ®Google Scholar
• Zhang JQ, Zhang ZR, Yang H, Tan QY, Qin SR, et al.: Lyophilized paclitaxel magnetoliposomes as a potential drug delivery system for breast carcinoma via parenteral administration: in vitro and in vivo studies. Pharm Res 22, 573–583, 2005.
   PubMed Web of Science ®Google Scholar
• Kikumori T, Kobayashi T, Sawaki M, and Imai T: Anti-cancer effect of hyperthermia on breast cancer by magnetite nanoparticle-loaded anti-HER2 immunoliposomes. Breast Cancer Res Treat 113, 435–441, 2009.
   PubMed Web of Science ®Google Scholar
• Yoshida M, Watanabe Y, Sato M, Maehara T, Aono H, et al.: Feasibility of chemohyperthermia with docetaxel-embedded magnetoliposomes as minimally invasive local treatment for cancer. Int J Cancer 126, 1955–1965, 2010.
   PubMed Web of Science ®Google Scholar
• Yan C, Wu Y, Feng J, Chen W, Liu X, et al.: Anti-αvβ3 antibody guided three-step pretargeting approach using magnetoliposomes for molecular magnetic resonance imaging of breast cancer angiogenesis. Int J Nanomedicine 8, 245–255, 2013.
   PubMed Web of Science ®Google Scholar
• Yang R, An LY, Miao QF, Li FM, Han Y, et al.: Effective elimination of liver cancer stem-like cells by CD90 antibody targeted thermosensitive magnetoliposomes. Oncotarget 7, 35894–35916, 2016.
   PubMedGoogle Scholar
• Khaleghi S, Rahbarizadeh F, Ahmadvand D, and Hosseini HRM: Anti-HER2 VHH targeted magnetoliposome for intelligent magnetic resonance imaging of breast cancer cells. Cell Mol Bioeng 10, 263–272, 2017.
   Web of Science ®Google Scholar
• Matos JOG, Rodrigues ARO, Almeida BG, Araújo JP, Castanheira EMS, et al.: Magnetic/Plasmonic MnFe2O4/Au Nanoparticles Covered with Lipid Bilayers for Applications in Thermotherapy. NaNaX 8-Nanoscience with Nanocrystals held at Braga, July 3–7, 2017.
   Google Scholar
• Pereira DSM, Rodrigues ARO, Almeida BG, Araújo JP, Machado VA, et al.: Magnetic Liposomes Containing Calcium Ferrite Nanoparticles for Breast Cancer Therapy. NaNaX 8-Nanoscience with Nanocrystals held at Braga, July 3–7, 2017.
   Google Scholar